ZP7-28985-98680
2 vaccinations
1 coded response
14 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 223 / VA
- Registered
- 2022-07-21
- Relationship
- Child or adolescent in my care
- Guardian
- WBR-31542-63478
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-30
Dose 1 — Pfizer-BioNTech
-
2022-07-21
Registered in v-safe
-
2022-07-21
Dose 2 — Pfizer-BioNTech
- 2022-07-21
- 2022-07-22
- 2022-07-23
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-08-04
- 2022-08-13
- 2022-08-20
- 2022-08-25
- 2022-09-01
- 2022-10-20
-
2023-01-21
Survey response — 6 months, dose 2, under 3MedDRA: Cough, Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-30 | Pfizer-BioNTech | No |
| 2 | 2022-07-21 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release